Market Overview:
The Europe medical cannabis market is currently witnessing moderate growth. Medical cannabis, or medical marijuana, refers to the plant-derived psychotropic drugs used for the treatment of various medical ailments. It is usually sourced from cannabis indica, sativa and hybrid cannabis plants and the active ingredients include tetrahydrocannabinol (THC) and cannabidiol (CBD). Medical cannabis products are manufactured in the form of oils, capsules and other edible products. They are used for treating chronic pain, anxiety, anorexia, muscle spasms and nausea. Apart from this, they are also effective in modulating the immune system, promoting neuroplasticity and improving vascular and digestive functioning.
The increasing prevalence of chronic medical ailments, such as cancer, arthritis, Alzheimer’s and migraine, is one of the key factors creating a positive outlook for the market. Furthermore, the widespread adoption of medical cannabis for pain management is providing a thrust to the market growth. It is usually inhaled, smoked, orally administered or topically applied to numb the pain receptors and provide instant relief to the patients. Additionally, the legalization of medical cannabis in Europe has enhanced the accessibility of the products through healthcare centers and authorized dispensaries, thereby contributing to the market growth. Other factors, including, extensive research and development (R&D) activities for optimizing the use of cannabinoids, along with improvements in the healthcare infrastructure, are anticipated to drive the market further. Looking forward, IMARC Group expects the market to witness moderate growth during 2021-2026.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe medical cannabis market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, species, derivative, application, end use and route of administration.
Breakup by Species:
Breakup by Derivative:
- Cannabidiol (CBD)
- Tetrahydrocannabinol (THC)
- Others
Breakup by Application:
- Cancer
- Arthritis
- Migraine
- Epilepsy
- Others
Breakup by End Use:
- Pharmaceutical Industry
- Research and Development Centres
- Others
Breakup by Route of Administration:
- Oral Solutions and Capsules
- Smoking
- Vaporizers
- Topicals
- Others
Breakup by Country:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key Questions Answered in This Report:
- How has the Europe medical cannabis market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Europe medical cannabis market?
- What are the key regional markets?
- What is the breakup of the market based on the species?
- What is the breakup of the market based on the derivative?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end use?
- What is the breakup of the market based on the route of administration?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the Europe medical cannabis market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Europe Medical Cannabis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Species
6.1 Indica
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Sativa
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Hybrid
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Derivative
7.1 Cannabidiol (CBD)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Tetrahydrocannabinol (THC)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Arthritis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Migraine
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Epilepsy
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End Use
9.1 Pharmaceutical Industry
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Research and Development Centres
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Route of Administration
10.1 Oral Solutions and Capsules
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Smoking
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Vaporizers
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Topicals
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by Country
11.1 Germany
11.1.1 Market Trends
11.1.2 Market Breakup by Species
11.1.3 Market Breakup by Derivative
11.1.4 Market Breakup by Application
11.1.5 Market Breakup by End Use
11.1.6 Market Breakup by Route of Administration
11.1.7 Market Forecast
11.2 France
11.2.1 Market Trends
11.2.2 Market Breakup by Species
11.2.3 Market Breakup by Derivative
11.2.4 Market Breakup by Application
11.2.5 Market Breakup by End Use
11.2.6 Market Breakup by Route of Administration
11.2.7 Market Forecast
11.3 United Kingdom
11.3.1 Market Trends
11.3.2 Market Breakup by Species
11.3.3 Market Breakup by Derivative
11.3.4 Market Breakup by Application
11.3.5 Market Breakup by End Use
11.3.6 Market Breakup by Route of Administration
11.3.7 Market Forecast
11.4 Italy
11.4.1 Market Trends
11.4.2 Market Breakup by Species
11.4.3 Market Breakup by Derivative
11.4.4 Market Breakup by Application
11.4.5 Market Breakup by End Use
11.4.6 Market Breakup by Route of Administration
11.4.7 Market Forecast
11.5 Spain
11.5.1 Market Trends
11.5.2 Market Breakup by Species
11.5.3 Market Breakup by Derivative
11.5.4 Market Breakup by Application
11.5.5 Market Breakup by End Use
11.5.6 Market Breakup by Route of Administration
11.5.7 Market Forecast
11.6 Others
11.6.1 Market Trends
11.6.2 Market Breakup by Species
11.6.3 Market Breakup by Derivative
11.6.4 Market Breakup by Application
11.6.5 Market Breakup by End Use
11.6.6 Market Breakup by Route of Administration
11.6.7 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Policy and Regulatory Landscape
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
List of Figures
Figure 1: Europe: Medical Cannabis Market: Major Drivers and Challenges
Figure 2: Europe: Medical Cannabis Market: Sales Value (in Million US$), 2015-2020
Figure 3: Europe: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Europe: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 5: Europe: Medical Cannabis Market: Breakup by Derivative (in %), 2020
Figure 6: Europe: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 7: Europe: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 8: Europe: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 9: Europe: Medical Cannabis Market: Breakup by Country (in %), 2020
Figure 10: Europe: Medical Cannabis (Indica) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Europe: Medical Cannabis (Indica) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Europe: Medical Cannabis (Sativa) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Europe: Medical Cannabis (Sativa) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Europe: Medical Cannabis (Hybrid) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Europe: Medical Cannabis (Hybrid) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Europe: Medical Cannabis (Cannabidiol-CBD) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Europe: Medical Cannabis (Cannabidiol-CBD) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Europe: Medical Cannabis (Tetrahydrocannabinol-THC) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Europe: Medical Cannabis (Tetrahydrocannabinol-THC) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Europe: Medical Cannabis (Other Derivatives) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Europe: Medical Cannabis (Other Derivatives) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Europe: Medical Cannabis (Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Europe: Medical Cannabis (Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Europe: Medical Cannabis (Arthritis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Europe: Medical Cannabis (Arthritis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Europe: Medical Cannabis (Migraine) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Europe: Medical Cannabis (Migraine) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Europe: Medical Cannabis (Epilepsy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Europe: Medical Cannabis (Epilepsy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Europe: Medical Cannabis (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Europe: Medical Cannabis (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Europe: Medical Cannabis (Pharmaceutical Industry) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Europe: Medical Cannabis (Pharmaceutical Industry) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Europe: Medical Cannabis (Research and Development Centres) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Europe: Medical Cannabis (Research and Development Centres) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Europe: Medical Cannabis (Other End Uses) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Europe: Medical Cannabis (Other End Uses) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Europe: Medical Cannabis (Oral Solutions and Capsules) Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Europe: Medical Cannabis (Oral Solutions and Capsules) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Europe: Medical Cannabis (Smoking) Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Europe: Medical Cannabis (Smoking) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Europe: Medical Cannabis (Vaporizers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Europe: Medical Cannabis (Vaporizers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Europe: Medical Cannabis (Topicals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Europe: Medical Cannabis (Topicals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Europe: Medical Cannabis (Other Route of Administrations) Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Europe: Medical Cannabis (Other Route of Administrations) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Germany: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Germany: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 50: Germany: Medical Cannabis Market: Breakup by Derivative (in %), 2020
Figure 51: Germany: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 52: Germany: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 53: Germany: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 54: Germany: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: France: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: France: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 57: France: Medical Cannabis Market: Breakup by Derivative (in %), 2020
Figure 58: France: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 59: France: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 60: France: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 61: France: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: United Kingdom: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: United Kingdom: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 64: United Kingdom: Medical Cannabis Market: Breakup by Derivative (in %), 2020
Figure 65: United Kingdom: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 66: United Kingdom: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 67: United Kingdom: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 68: United Kingdom: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Italy: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Italy: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 71: Italy: Medical Cannabis Market: Breakup by Derivative (in %), 2020
Figure 72: Italy: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 73: Italy: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 74: Italy: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 75: Italy: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Spain: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Spain: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 78: Spain: Medical Cannabis Market: Breakup by Derivative (in %), 2020
Figure 79: Spain: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 80: Spain: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 81: Spain: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 82: Spain: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Others: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Others: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Europe: Medical Cannabis Industry: SWOT Analysis
Figure 86: Europe: Medical Cannabis Industry: Value Chain Analysis
Figure 87: Europe: Medical Cannabis Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Europe: Medical Cannabis Market: Key Industry Highlights, 2020 and 2026
Table 2: Europe: Medical Cannabis Market Forecast: Breakup by Species (in Million US$), 2021-2026
Table 3: Europe: Medical Cannabis Market Forecast: Breakup by Derivative (in Million US$), 2021-2026
Table 4: Europe: Medical Cannabis Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Europe: Medical Cannabis Market Forecast: Breakup by End Use (in Million US$), 2021-2026
Table 6: Europe: Medical Cannabis Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 7: Europe: Medical Cannabis Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 8: Europe: Medical Cannabis Market: Competitive Structure
Table 9: Europe: Medical Cannabis Market: Key Players